Abernethy Mattinsider trades

In SEC Form 4 filings, Abernethy Matt is listed as Chief Financial Officer of Neurocrine Biosciences Inc (NBIX). In the last 90 days, Abernethy Matt sold $363.3K of Neurocrine Biosciences Inc (NBIX) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
NBIXNeurocrine Biosciences Inc	Chief Financial Officer	3	Sep 15

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-15

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
NBIXNeurocrine Biosciences Inc	Sep 14	Sep 15	S	2,311	$157.20	Sale −$363,285	42,808	Yes	Form 4
NBIXNeurocrine Biosciences Inc	Sep 11	Sep 15	A	5,020	$0.00	$0	47,828	Yes	Form 4
NBIXNeurocrine Biosciences Inc	Sep 11	Sep 15	F	2,709	$156.22	$423,200	45,119	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.